A complete application in a minute — tailored resume and cover letter, ready to send.
Natera is seeking a Women's Health Strategic Account Manager to join the team and work with the local women's health sales group to grow Natera's tests across IDNs, large hospital systems, and Academic Medical Centers. You will lead strategic account plans, educate partners, and collaborate with cross-functional teams to drive adoption of our women’s health portfolio.
The role requires 3+ years in physician sales, strong strategic selling skills, and a proven track record in generating growth.
The territory for this position includes Georgia, Alabama and Florida and will require 75%+ of travel.
We are hiring a Women's Health Strategic Account Manager (SAM) to join Natera! The Strategic Account Manager works with the local women's health sales team to develop and execute strategies to increase Natera testing in IDNs, large hospital systems and Academic Medical Centers. This role involves internal collaboration, leading without authority, and forming relationships with key senior level influencers within health systems.
The total on-target earnings (OTE) package includes a competitive base salary along with uncapped quarterly commissions. Beyond OTE, the compensation also features a car allowance and Restricted Stock Units (RSUs).
The compensation package listed is for 1st year OTE, which are based on a wide array of factors unique to each candidate, including but not limited to skill set, years & depth of experience, certifications and specific office location. On-target earnings (OTE) represent the total potential income an employee can earn by achieving 100% of their performance goals. It combines a base salary with commissions and serves as an estimated figure rather than a guaranteed amount, providing a guideline based on average performance outcomes.
On-target earnings (OTE)
$190,000 - $220,000 USD
Natera is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women's health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to